Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.
News
Number of global deaths by suicide increased over 30 years
News
MRI is a poor disability predictor in secondary progressive MS
News
Progressive disability in MS explained?
News
Atogepant reduces migraine days: ADVANCE trial results published
News
Guidance on additional COVID-19 vaccine dose for MS patients
News
Virtual roller-coaster may explain the ups and downs of migraine
News
Is walking speed following stroke a good predictor of recovery?
News
Novel NSAID–triptan drug effectively relieves migraine pain
News
No increased risk of hypertension with erenumab?
News
A large proportion of migraine patients are not offered preventive treatment
News
Almost half of patients with migraine are reluctant to seek care
News
A new biomarker of traumatic brain injury?
News
NfL beats T-tau as a prognostic marker of cognitive decline
News
